Notes
Global Alliance for Vaccines and Immunizations
The study was funded by Glaxo SmithKline Biologicals S.A.
Reference
Sauboin C, et al. Comparing the Estimated Public Health Impact and Cost-Effectiveness of Phid-Cv and Pcv-13 in the Routine Immunisation Programme in Gavi-Eligible Countries (Sub-Saharan Africa and Asia/Oceania): a Modelling Study. 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PIN34, 10 Nov 2018. Available from: URL: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/85979?pdfid=56806
Rights and permissions
About this article
Cite this article
Assessing cost effectiveness of pneumococcal conjugate vaccines. PharmacoEcon Outcomes News 817, 8 (2018). https://doi.org/10.1007/s40274-018-5465-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5465-2